US Patent Issued to Viktor Veniaminovich Tets on Jan. 27 for "Vaccine comprising protein-targeted (PT) extracellular DNA isolated from bacterial matrix" (New York Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,535,491, issued on Jan. 27, was assigned to Viktor Veniaminovich Tets (New York).

"Vaccine comprising protein-targeted (PT) extracellular DNA isolated from bacterial matrix" was invented by Viktor Veniaminovich Tets (New York) and Georgy Viktorovich Tets (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to diagnosis, prevention, and treatment of diseases and conditions associated with the functions of prion-like or Tetz-proteins."

The patent was filed on April 8, 2019, under Application No. 17/051,598.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sec...